Literature DB >> 21240919

Sprouty2 and -4 regulate axon outgrowth by hippocampal neurons.

Barbara Hausott1, Natalie Vallant, Bettina Schlick, Maria Auer, Benedikt Nimmervoll, Gerald J Obermair, Christoph Schwarzer, Fangping Dai, Beate Brand-Saberi, Lars Klimaschewski.   

Abstract

Sprouty proteins act as negative feedback inhibitors of fibroblast growth factor (FGF) signaling. FGFs belong to the neurotrophic factors and are involved in axonal growth during development and repair. We investigated the expression of Sprouty isoforms in hippocampal neurons as well as the regulation of Sprouty2 and -4 during development and their role in axon growth. Sprouty2 and -4 were located in the nucleus, the cytoplasm, in dendrites, and axons of hippocampal neurons concentrated in growth cones. During development in vivo and differentiation in vitro, expression of Sprouty2 and -4 was gradually downregulated in hippocampal neurons. Between 5 and 24 days in culture expression of both Sprouty isoforms was reduced by 70%. In vivo expression of Sprouty2 was reduced by 79% and of Sprouty4 by 93% on postnatal day 14 compared to embryonic day 16.5. Downregulation of Sprouty2 and -4 by shRNAs strongly promoted elongative axon growth by cultured hippocampal neurons, which was further increased by FGF-2 treatment. In addition, FGF-2 reduced expression of Sprouty2 by 33% and of Sprouty4 by 44%. Together, our results imply that Sprouty2 and -4 are downregulated in the hippocampus during postnatal brain development and that they can act as regulators of developmental axon growth.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21240919     DOI: 10.1002/hipo.20910

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  9 in total

Review 1.  Signal Transduction Regulators in Axonal Regeneration.

Authors:  Barbara Hausott; Rudolf Glueckert; Anneliese Schrott-Fischer; Lars Klimaschewski
Journal:  Cells       Date:  2022-05-04       Impact factor: 7.666

2.  Synaptic activity-induced glycolysis facilitates membrane lipid provision and neurite outgrowth.

Authors:  Marc Segarra-Mondejar; Sergi Casellas-Díaz; Marina Ramiro-Pareta; Claudia Müller-Sánchez; Alejandro Martorell-Riera; Ismaïl Hermelo; Manuel Reina; Julián Aragonés; Ofelia M Martínez-Estrada; Francesc X Soriano
Journal:  EMBO J       Date:  2018-04-03       Impact factor: 11.598

Review 3.  Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease.

Authors:  Richard Quinton; Marco Bonomi; Biagio Cangiano; Du Soon Swee
Journal:  Hum Genet       Date:  2020-03-21       Impact factor: 4.132

4.  Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism.

Authors:  Hichem Miraoui; Andrew A Dwyer; Gerasimos P Sykiotis; Lacey Plummer; Wilson Chung; Bihua Feng; Andrew Beenken; Jeff Clarke; Tune H Pers; Piotr Dworzynski; Kimberley Keefe; Marek Niedziela; Taneli Raivio; William F Crowley; Stephanie B Seminara; Richard Quinton; Virginia A Hughes; Philip Kumanov; Jacques Young; Maria A Yialamas; Janet E Hall; Guy Van Vliet; Jean-Pierre Chanoine; John Rubenstein; Moosa Mohammadi; Pei-San Tsai; Yisrael Sidis; Kasper Lage; Nelly Pitteloud
Journal:  Am J Hum Genet       Date:  2013-05-02       Impact factor: 11.025

Review 5.  Fibroblast Growth Factor Signalling in the Diseased Nervous System.

Authors:  Lars Klimaschewski; Peter Claus
Journal:  Mol Neurobiol       Date:  2021-04-15       Impact factor: 5.590

6.  Comprehensive whole genome sequence analyses yields novel genetic and structural insights for Intellectual Disability.

Authors:  Farah R Zahir; Jill C Mwenifumbo; Hye-Jung E Chun; Emilia L Lim; Clara D M Van Karnebeek; Madeline Couse; Karen L Mungall; Leora Lee; Nancy Makela; Linlea Armstrong; Cornelius F Boerkoel; Sylvie L Langlois; Barbara M McGillivray; Steven J M Jones; Jan M Friedman; Marco A Marra
Journal:  BMC Genomics       Date:  2017-05-24       Impact factor: 3.969

7.  Sprouty2 and -4 hypomorphism promotes neuronal survival and astrocytosis in a mouse model of kainic acid induced neuronal damage.

Authors:  Sitthisak Thongrong; Barbara Hausott; Letizia Marvaldi; Alexandra S Agostinho; Luca Zangrandi; Johannes Burtscher; Barbara Fogli; Christoph Schwarzer; Lars Klimaschewski
Journal:  Hippocampus       Date:  2015-11-27       Impact factor: 3.899

Review 8.  Sprouty2-a Novel Therapeutic Target in the Nervous System?

Authors:  Barbara Hausott; Lars Klimaschewski
Journal:  Mol Neurobiol       Date:  2018-09-17       Impact factor: 5.590

9.  Sprouty3 and Sprouty4, Two Members of a Family Known to Inhibit FGF-Mediated Signaling, Exert Opposing Roles on Proliferation and Migration of Glioblastoma-Derived Cells.

Authors:  Burcu Emine Celik-Selvi; Astrid Stütz; Christoph-Erik Mayer; Jihen Salhi; Gerald Siegwart; Hedwig Sutterlüty
Journal:  Cells       Date:  2019-08-01       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.